Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 7:48 pm Sale |
2024-09-30 | 13G | Lyra Therapeutics, Inc. LYRA |
Point72 Asset Management, L.P. | 0 0.000% |
-60,606 (Position Closed) |
Filing History |
| 2024-11-14 7:48 pm Sale |
2024-09-30 | 13G | Corbus Pharmaceuticals Holdings, Inc. CRBP |
Point72 Asset Management, L.P. | 0 0.000% |
-388,676 (Position Closed) |
Filing History |
| 2024-11-14 7:47 pm Sale |
2024-09-30 | 13G | Pulmonx Corporation LUNG |
Point72 Asset Management, L.P. | 0 0.000% |
-1,936,083 (Position Closed) |
Filing History |
| 2024-11-14 7:47 pm Sale |
2024-09-30 | 13G | Celldex Therapeutics, Inc. CLDX |
Point72 Asset Management, L.P. | 1,684,032 2.500% |
-1,072,090 (-38.90%) |
Filing History |
| 2024-11-14 7:46 pm Sale |
2024-09-30 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 1,520,007 3.600% |
-1,049,819 (-40.85%) |
Filing History |
| 2024-10-23 6:01 pm Purchase |
2024-10-16 | 13G | Bright Minds Biosciences Inc. DRUG |
Point72 Asset Management, L.P. | 435,000 9.700% |
435,000 (New Position) |
Filing History |
| 2024-10-21 5:05 pm Purchase |
2024-10-18 | 13G | Shoals Technologies Group, Inc. SHLS |
Point72 Asset Management, L.P. | 9,029,023 5.400% |
9,029,023 (New Position) |
Filing History |
| 2024-10-15 5:01 pm Purchase |
2024-10-14 | 13G | aTyr Pharma, Inc. ATYR |
Point72 Asset Management, L.P. | 5,039,846 6.200% |
5,039,846 (New Position) |
Filing History |
| 2024-10-10 4:10 pm Purchase |
2024-10-09 | 13G | Inhibikase Therapeutics, Inc. IKT |
Point72 Asset Management, L.P. | 625,000 8.400% |
625,000 (New Position) |
Filing History |
| 2024-09-05 4:36 pm Purchase |
2024-09-04 | 13G | Teladoc Health, Inc. TDOC |
Point72 Asset Management, L.P. | 8,754,723 5.100% |
8,754,723 (New Position) |
Filing History |
| 2024-07-02 6:10 pm Purchase |
2024-07-01 | 13G | Lumentum Holdings Inc. LITE |
Point72 Asset Management, L.P. | 3,382,398 5.000% |
3,382,398 (New Position) |
Filing History |
| 2024-06-24 4:51 pm Purchase |
2024-06-14 | 13G | UroGen Pharma Ltd. URGN |
Point72 Asset Management, L.P. | 2,569,826 6.200% |
2,569,826 (New Position) |
Filing History |
| 2024-06-24 4:16 pm Purchase |
2024-06-21 | 13G | Sphere Entertainment Co. SPHR |
Point72 Asset Management, L.P. | 1,560,170 5.500% |
1,560,170 (New Position) |
Filing History |
| 2024-06-14 4:34 pm Purchase |
2024-06-04 | 13G | Olema Pharmaceuticals, Inc. OLMA |
Point72 Asset Management, L.P. | 3,225,250 5.700% |
3,225,250 (New Position) |
Filing History |
| 2024-06-10 4:29 pm Purchase |
2024-06-07 | 13G | Maravai LifeSciences Holdings, Inc. MRVI |
Point72 Asset Management, L.P. | 6,647,015 5.000% |
6,647,015 (New Position) |
Filing History |
| 2024-05-21 4:56 pm Purchase |
2024-05-20 | 13G | Rapid7, Inc. RPD |
Point72 Asset Management, L.P. | 3,121,415 5.000% |
1,243,804 (+66.24%) |
Filing History |
| 2024-05-09 5:29 pm Purchase |
2024-05-02 | 13G | Corvus Pharmaceuticals, Inc. CRVS |
Point72 Asset Management, L.P. | 17,050,384 9.900% |
17,050,384 (New Position) |
Filing History |
| 2024-04-26 4:15 pm Purchase |
2024-04-25 | 13G | Avid Bioservices, Inc. CDMO |
Point72 Asset Management, L.P. | 3,226,006 5.100% |
3,226,006 (New Position) |
Filing History |
| 2024-04-05 4:05 pm Purchase |
2024-04-04 | 13G | Sutro Biopharma, Inc. STRO |
Point72 Asset Management, L.P. | 5,932,908 7.900% |
5,932,908 (New Position) |
Filing History |
| 2024-03-26 4:21 pm Purchase |
2024-03-25 | 13G | Fox Corporation FOXA |
Point72 Asset Management, L.P. | 12,046,118 5.000% |
12,046,118 (New Position) |
Filing History |